PRRT2-related paroxysmal dyskinesia with overlapping paroxysmal kinesigenic and paroxysmal non-kinesigenic dyskinesia-like phenotypes: a case report

Background Paroxysmal dyskinesias (PDs) are a heterogeneous group of episodic movement disorders classified according to their clinical features into paroxysmal kinesigenic dyskinesia (PKD), paroxysmal non-kinesigenic dyskinesia (PNKD), and paroxysmal exercise-induced dyskinesia (PED). Distinct genetic causes have been identified for these subtypes, with PRRT2 being a major causative gene for PKD. Although PRRT2 -related PD typically presents as PKD and responds well to low-dose carbamazepine, atypical phenotypes and variable treatment responses have been reported. Case presentation A male patient with a history of self-limited infantile epilepsy developed exercise-triggered involuntary movements at 6 years of age. At 7 years and 3 months, the attacks became more frequent and were predominantly triggered by anxiety and stress. They occurred multiple times daily, lasted from several minutes to hours, and comprised choreoathetoid and ballistic movements of the limbs and face. Neurological examination, brain magnetic resonance imaging, and electroencephalogram findings were unremarkable. The clinical features overlapped with those of PKD and PNKD, precluding conventional subtype classification. Carbamazepine monotherapy was insufficient, whereas the addition of clonazepam markedly reduced attack frequency. Genetic testing identified a heterozygous PRRT2 NM_145239.3:c.649dup (p.Arg217ProfsTer8) variant. Conclusions This case demonstrates the phenotypic and therapeutic variability in PRRT2 -related PDs. Despite having a common pathogenic PRRT2 variant, the patient exhibited age-dependent change in dyskinetic phenomenology, coexistence of PKD- and PNKD-like features within a single attack, and a favourable response to combined carbamazepine and clonazepam therapy. These findings highlight the importance of considering the clinical phenotype, in addition to genotype, in the management of PDs.

Authors

Institutions

Publication Details

Journal
Brain and Development Case Reports
Published
2026-11-13
DOI
https://doi.org/10.1016/j.bdcasr.2026.100169
Primary Topic
Neurological and metabolic disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PRRT2-related paroxysmal dyskinesia with overlapping paroxysmal kinesigenic and paroxysmal non-kinesigenic dyskinesia-like phenotypes: a case report

Nobuhiko Okamoto, 泰祐 尾上, Hitomi Arahori, Shizuka Nishimoto et al.
1 links
Brain and Development Case Reports
Neurological and metabolic disorders
article

PRRT2-related paroxysmal dyskinesia with overlapping paroxysmal kinesigenic and paroxysmal non-kinesigenic dyskinesia-like phenotypes: a case report

Nobuhiko Okamoto, 泰祐 尾上, Hitomi Arahori, Shizuka Nishimoto, Kosuke Chayama, Yukihiro Kitai, Yasuyuki Tokunaga, Kunihiko Takahashi, Kyoko Noguchi, Kazuho Sato, Ryotaro Kawakami, Yui Nagasawa, Shota Hamano
article en

Abstract

Background Paroxysmal dyskinesias (PDs) are a heterogeneous group of episodic movement disorders classified according to their clinical features into paroxysmal kinesigenic dyskinesia (PKD), paroxysmal non-kinesigenic dyskinesia (PNKD), and paroxysmal exercise-induced dyskinesia (PED). Distinct genetic causes have been identified for these subtypes, with PRRT2 being a major causative gene for PKD. Although PRRT2 -related PD typically presents as PKD and responds well to low-dose carbamazepine, atypical phenotypes and variable treatment responses have been reported. Case presentation A male patient with a history of self-limited infantile epilepsy developed exercise-triggered involuntary movements at 6 years of age. At 7 years and 3 months, the attacks became more frequent and were predominantly triggered by anxiety and stress. They occurred multiple times daily, lasted from several minutes to hours, and comprised choreoathetoid and ballistic movements of the limbs and face. Neurological examination, brain magnetic resonance imaging, and electroencephalogram findings were unremarkable. The clinical features overlapped with those of PKD and PNKD, precluding conventional subtype classification. Carbamazepine monotherapy was insufficient, whereas the addition of clonazepam markedly reduced attack frequency. Genetic testing identified a heterozygous PRRT2 NM_145239.3:c.649dup (p.Arg217ProfsTer8) variant. Conclusions This case demonstrates the phenotypic and therapeutic variability in PRRT2 -related PDs. Despite having a common pathogenic PRRT2 variant, the patient exhibited age-dependent change in dyskinetic phenomenology, coexistence of PKD- and PNKD-like features within a single attack, and a favourable response to combined carbamazepine and clonazepam therapy. These findings highlight the importance of considering the clinical phenotype, in addition to genotype, in the management of PDs.

Brain and Development Case ReportsVol. 4(4)
Toyonaka Municipal Hospital (JP), Osaka Women's and Children's Hospital (JP)
Good health and well-being
Neurological and metabolic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon